Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV
CompletedOBSERVATIONAL
Enrollment
42
Participants
Timeline
Start Date
July 31, 2011
Primary Completion Date
September 30, 2012
Study Completion Date
September 30, 2012
Conditions
KwashiorkorMarasmusSevere Acute MalnutritionHIV
Interventions
DRUG
zidovudine, lamivudine, nevirapine
Trial Locations (1)
Unknown
Queen Elizabeth Central Hospital, Blantyre
All Listed Sponsors
lead
Washington University School of Medicine
OTHER
NCT01529125 - Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV | Biotech Hunter | Biotech Hunter